These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33919255)

  • 1. Impaired 26S Proteasome Assembly Precedes Neuronal Loss in Mutant UBQLN2 Rats.
    Zhang W; Huang B; Gao L; Huang C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS.
    Kim SH; Stiles SG; Feichtmeier JM; Ramesh N; Zhan L; Scalf MA; Smith LM; Pandey UB; Tibbetts RS
    Hum Mol Genet; 2018 Jan; 27(2):322-337. PubMed ID: 29161404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Ubqln2 expression causes neuron death in transgenic rats.
    Huang B; Wu Q; Zhou H; Huang C; Xia XG
    J Neurochem; 2016 Oct; 139(2):285-293. PubMed ID: 27456931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
    Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N
    Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity.
    Sharkey LM; Sandoval-Pistorius SS; Moore SJ; Gerson JE; Komlo R; Fischer S; Negron-Rios KY; Crowley EV; Padron F; Patel R; Murphy GG; Paulson HL
    Neurobiol Dis; 2020 Sep; 143():105016. PubMed ID: 32653673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.
    Higgins NR; Greenslade JE; Wu JJ; Miranda E; Galliciotti G; Monteiro MJ
    Brain Pathol; 2021 Sep; 31(5):e12948. PubMed ID: 33780087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global proteomics of Ubqln2-based murine models of ALS.
    Whiteley AM; Prado MA; de Poot SAH; Paulo JA; Ashton M; Dominguez S; Weber M; Ngu H; Szpyt J; Jedrychowski MP; Easton A; Gygi SP; Kurz T; Monteiro MJ; Brown EJ; Finley D
    J Biol Chem; 2021; 296():100153. PubMed ID: 33277362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice.
    Ceballos-Diaz C; Rosario AM; Park HJ; Chakrabarty P; Sacino A; Cruz PE; Siemienski Z; Lara N; Moran C; Ravelo N; Golde TE; McFarland NR
    Mol Neurodegener; 2015 Jul; 10():25. PubMed ID: 26152284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant UBQLN2
    Chen T; Huang B; Shi X; Gao L; Huang C
    Acta Neuropathol Commun; 2018 Nov; 6(1):122. PubMed ID: 30409191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquilin 2: a component of the ubiquitin-proteasome system with an emerging role in neurodegeneration.
    Zhang KY; Yang S; Warraich ST; Blair IP
    Int J Biochem Cell Biol; 2014 May; 50():123-6. PubMed ID: 24589709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
    Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
    Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2.
    Gorrie GH; Fecto F; Radzicki D; Weiss C; Shi Y; Dong H; Zhai H; Fu R; Liu E; Li S; Arrat H; Bigio EH; Disterhoft JF; Martina M; Mugnaini E; Siddique T; Deng HX
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14524-9. PubMed ID: 25246588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBQLN proteins in health and disease with a focus on UBQLN2 in ALS/FTD.
    Lin BC; Higgins NR; Phung TH; Monteiro MJ
    FEBS J; 2022 Oct; 289(20):6132-6153. PubMed ID: 34273246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2.
    Osaka M; Ito D; Suzuki N
    Biochem Biophys Res Commun; 2016 Apr; 472(2):324-31. PubMed ID: 26944018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.
    Renaud L; Picher-Martel V; Codron P; Julien JP
    Acta Neuropathol Commun; 2019 Jul; 7(1):103. PubMed ID: 31319884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis (ALS) linked mutation in Ubiquilin 2 affects stress granule assembly via TIA-1.
    Peng G; Gu A; Niu H; Chen L; Chen Y; Zhou M; Zhang Y; Liu J; Cai L; Liang D; Liu X; Liu M
    CNS Neurosci Ther; 2022 Jan; 28(1):105-115. PubMed ID: 34750982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.
    Alexander EJ; Ghanbari Niaki A; Zhang T; Sarkar J; Liu Y; Nirujogi RS; Pandey A; Myong S; Wang J
    Proc Natl Acad Sci U S A; 2018 Dec; 115(49):E11485-E11494. PubMed ID: 30442662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis.
    Teyssou E; Chartier L; Amador MD; Lam R; Lautrette G; Nicol M; Machat S; Da Barroca S; Moigneu C; Mairey M; Larmonier T; Saker S; Dussert C; Forlani S; Fontaine B; Seilhean D; Bohl D; Boillée S; Meininger V; Couratier P; Salachas F; Stevanin G; Millecamps S
    Neurobiol Aging; 2017 Oct; 58():239.e11-239.e20. PubMed ID: 28716533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.
    Deng HX; Chen W; Hong ST; Boycott KM; Gorrie GH; Siddique N; Yang Y; Fecto F; Shi Y; Zhai H; Jiang H; Hirano M; Rampersaud E; Jansen GH; Donkervoort S; Bigio EH; Brooks BR; Ajroud K; Sufit RL; Haines JL; Mugnaini E; Pericak-Vance MA; Siddique T
    Nature; 2011 Aug; 477(7363):211-5. PubMed ID: 21857683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
    Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
    Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.